Claudin18.2 是肿瘤靶向免疫治疗的新型分子生物标志物
Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy.
62.5分
★★★☆☆
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
DISEASE HUB
肿瘤细胞治疗研究
DISEASE HUB
FOR TREATMENT
按「中国试验优先 → 正在招募 → 更新更近」排序。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性，以登记原文和主治医生判断为准。
FOR RESEARCH
Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy.
MEMBER ACCOUNT
登录成功会直接打开下一页。